CXCR4 and osteosarcoma: Solubility limitations prevented the evaluation of peptide T in vivo, but peptides, R, I and S, reduced lung metastases in mice injected with B16-CXCR4 mouse melanoma cells and K7M2 mouse osteosarcoma cells.